Prostate Cancer Diagnostics Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Prostate Cancer Diagnostics Market covers analysis by Type (Priliminary Tests and Confirmatory Tests), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00003656
  • Category : Medical Device
  • No. of Pages : 150
Buy Now

Prostate Cancer Diagnostics Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Buy Now

MARKET OVERVIEW

Prostate cancer diagnostics refers to the various tests and procedures used to diagnose prostate cancer in men. Early detection of prostate cancer is important for successful treatment and recovery. Several different diagnostic tests are available, including digital rectal exams, prostate-specific antigen (PSA) tests, and biopsies. With the increasing prevalence of prostate cancer, the demand for effective and reliable diagnostic tools is growing, and the prostate cancer diagnostics market is expected to continue to grow in the coming years. The market includes a wide range of products and services, including diagnostic imaging technologies, biopsy devices, and laboratory tests.

MARKET DYNAMICS

The prostate cancer diagnostics market is anticipated to grow in the forecast period owing to driving factors such as the increasing prevalence of disease requiring surgical treatment, the increasing prevalence of cancer and hernia, and the growing number of bariatric surgeries, etc. Growing healthcare expenditure and introduction of advanced technologies in minimally invasive surgeries, growing insurance coverage, and the inclination of surgeons to prescribe minimally invasive surgeries to patients due to early post-operative recovery and lower post-operative complications are also likely to drive the market growth for the prostate cancer diagnostics market during the forecast period.

MARKET SCOPE

The "Global Prostate Cancer Diagnostics Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of prostate cancer diagnostics market with detailed market segmentation by type, and geography. The global prostate cancer diagnostics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading prostate cancer diagnostics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global prostate cancer diagnostics market is segmented on the basis of type which is sub segmented as preliminary tests and confirmatory test. The confirmatory test segment is further sub segmented as PCA3 tests, trans rectal ultrasound, and biopsy.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry, including both qualitative and quantitative information. It provides an overview and forecast of the global Prostate Cancer Diagnostics Market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA), and South & Central America. The Prostate Cancer Diagnostics Market by each region is later sub-segmented by respective countries and segments. The report covers an analysis and forecast of 18 countries globally, along with current trends and opportunities prevailing in the region.

The report analyzes factors affecting prostate cancer diagnostics market from both the demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides an exhaustive PEST analysis for all five regions, namely, North America, Europe, APAC, MEA, and South & Central America after evaluating political, economic, social, and technological factors affecting the Prostate Cancer Diagnostics Market in these regions.

World Geography

Have a question?

Analyst

Mrinal

Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst   Speak to Analyst
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
MARKET PLAYERS

The report provides a detailed overview of the industry, including both qualitative and quantitative information. It provides an overview and forecast of the global Prostate Cancer Diagnostics Market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA), and South & Central America. The Prostate Cancer Diagnostics Market by each region is later sub-segmented by respective countries and segments. The report covers an analysis and forecast of 18 countries globally, along with current trends and opportunities prevailing in the region.

The report analyzes factors affecting prostate cancer diagnostics market from both the demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides an exhaustive PEST analysis for all five regions, namely, North America, Europe, APAC, MEA, and South & Central America after evaluating political, economic, social, and technological factors affecting the Prostate Cancer Diagnostics Market in these regions.

MARKET PLAYERS

The reports cover key developments in the prostate cancer diagnostics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals, and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnerships & collaborations. These activities have paved the way for the expansion of business and customer base of market players. The market payers Prostate Cancer Diagnostics Market are anticipated to have lucrative growth opportunities in the future with the rising demand for Surgical Retractors in the global market. Below mentioned is the list of a few companies engaged in the Surgical Retractors market.

The report also includes the profiles of key prostate cancer diagnostics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of the last three years, and key development in the past five years.

  • MDxHealth
  • Telo Genomics Corp (3D Signatures)
  • Genomic Health , Inc.
  • Abbott
  • OPKO Health, INC.
  • Siemens Healthcare GmbH
  • DiaSorin S.p.A
  • BioMerieux SA
  • F. Hoffman La Roche Ltd.
  • Danaher Corporation (Beckman Coulter, Inc.)

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Prostate Cancer Diagnostics Market - By Type
1.3.2 Prostate Cancer Diagnostics Market - By Region
1.3.2.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. PROSTATE CANCER DIAGNOSTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PROSTATE CANCER DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. PROSTATE CANCER DIAGNOSTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. PROSTATE CANCER DIAGNOSTICS - GLOBAL MARKET OVERVIEW
6.2. PROSTATE CANCER DIAGNOSTICS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. PROSTATE CANCER DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. PRELIMINARY TESTS
7.3.1. Overview
7.3.2. Preliminary Tests Market Forecast and Analysis
7.4. CONFIRMATORY TESTS
7.4.1. Overview
7.4.2. Confirmatory Tests Market Forecast and Analysis
7.4.3. PCA3 Tests Market
7.4.3.1. Overview
7.4.3.2. PCA3 Tests Market Forecast and Analysis
7.4.4. Trans Rectal Ultrasound Market
7.4.4.1. Overview
7.4.4.2. Trans Rectal Ultrasound Market Forecast and Analysis
7.4.5. Biopsy Market
7.4.5.1. Overview
7.4.5.2. Biopsy Market Forecast and Analysis
8. PROSTATE CANCER DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1 North America Prostate Cancer Diagnostics Market Overview
8.1.2 North America Prostate Cancer Diagnostics Market Forecasts and Analysis
8.1.3 North America Prostate Cancer Diagnostics Market Forecasts and Analysis - By Type
8.1.4 North America Prostate Cancer Diagnostics Market Forecasts and Analysis - By Countries
8.1.4.1 United States Prostate Cancer Diagnostics Market
8.1.4.1.1 United States Prostate Cancer Diagnostics Market by Type
8.1.4.2 Canada Prostate Cancer Diagnostics Market
8.1.4.2.1 Canada Prostate Cancer Diagnostics Market by Type
8.1.4.3 Mexico Prostate Cancer Diagnostics Market
8.1.4.3.1 Mexico Prostate Cancer Diagnostics Market by Type
8.1.4.4 US Prostate Cancer Diagnostics Market
8.1.4.4.1 US Prostate Cancer Diagnostics Market by Type
8.2. EUROPE
8.2.1 Europe Prostate Cancer Diagnostics Market Overview
8.2.2 Europe Prostate Cancer Diagnostics Market Forecasts and Analysis
8.2.3 Europe Prostate Cancer Diagnostics Market Forecasts and Analysis - By Type
8.2.4 Europe Prostate Cancer Diagnostics Market Forecasts and Analysis - By Countries
8.2.4.1 Germany Prostate Cancer Diagnostics Market
8.2.4.1.1 Germany Prostate Cancer Diagnostics Market by Type
8.2.4.2 France Prostate Cancer Diagnostics Market
8.2.4.2.1 France Prostate Cancer Diagnostics Market by Type
8.2.4.3 Italy Prostate Cancer Diagnostics Market
8.2.4.3.1 Italy Prostate Cancer Diagnostics Market by Type
8.2.4.4 Spain Prostate Cancer Diagnostics Market
8.2.4.4.1 Spain Prostate Cancer Diagnostics Market by Type
8.2.4.5 United Kingdom Prostate Cancer Diagnostics Market
8.2.4.5.1 United Kingdom Prostate Cancer Diagnostics Market by Type
8.3. ASIA-PACIFIC
8.3.1 Asia-Pacific Prostate Cancer Diagnostics Market Overview
8.3.2 Asia-Pacific Prostate Cancer Diagnostics Market Forecasts and Analysis
8.3.3 Asia-Pacific Prostate Cancer Diagnostics Market Forecasts and Analysis - By Type
8.3.4 Asia-Pacific Prostate Cancer Diagnostics Market Forecasts and Analysis - By Countries
8.3.4.1 Australia Prostate Cancer Diagnostics Market
8.3.4.1.1 Australia Prostate Cancer Diagnostics Market by Type
8.3.4.2 China Prostate Cancer Diagnostics Market
8.3.4.2.1 China Prostate Cancer Diagnostics Market by Type
8.3.4.3 India Prostate Cancer Diagnostics Market
8.3.4.3.1 India Prostate Cancer Diagnostics Market by Type
8.3.4.4 Japan Prostate Cancer Diagnostics Market
8.3.4.4.1 Japan Prostate Cancer Diagnostics Market by Type
8.3.4.5 South Korea Prostate Cancer Diagnostics Market
8.3.4.5.1 South Korea Prostate Cancer Diagnostics Market by Type
8.4. MIDDLE EAST AND AFRICA
8.4.1 Middle East and Africa Prostate Cancer Diagnostics Market Overview
8.4.2 Middle East and Africa Prostate Cancer Diagnostics Market Forecasts and Analysis
8.4.3 Middle East and Africa Prostate Cancer Diagnostics Market Forecasts and Analysis - By Type
8.4.4 Middle East and Africa Prostate Cancer Diagnostics Market Forecasts and Analysis - By Countries
8.4.4.1 South Africa Prostate Cancer Diagnostics Market
8.4.4.1.1 South Africa Prostate Cancer Diagnostics Market by Type
8.4.4.2 Saudi Arabia Prostate Cancer Diagnostics Market
8.4.4.2.1 Saudi Arabia Prostate Cancer Diagnostics Market by Type
8.4.4.3 U.A.E Prostate Cancer Diagnostics Market
8.4.4.3.1 U.A.E Prostate Cancer Diagnostics Market by Type
8.5. SOUTH AND CENTRAL AMERICA
8.5.1 South and Central America Prostate Cancer Diagnostics Market Overview
8.5.2 South and Central America Prostate Cancer Diagnostics Market Forecasts and Analysis
8.5.3 South and Central America Prostate Cancer Diagnostics Market Forecasts and Analysis - By Type
8.5.4 South and Central America Prostate Cancer Diagnostics Market Forecasts and Analysis - By Countries
8.5.4.1 Brazil Prostate Cancer Diagnostics Market
8.5.4.1.1 Brazil Prostate Cancer Diagnostics Market by Type
8.5.4.2 Argentina Prostate Cancer Diagnostics Market
8.5.4.2.1 Argentina Prostate Cancer Diagnostics Market by Type
9. INDUSTRY LANDSCAPE
9.1. MERGERS AND ACQUISITIONS
9.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
9.3. NEW PRODUCT LAUNCHES
9.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
10. PROSTATE CANCER DIAGNOSTICS MARKET, KEY COMPANY PROFILES
10.1. MDXHEALTH
10.1.1. Key Facts
10.1.2. Business Description
10.1.3. Products and Services
10.1.4. Financial Overview
10.1.5. SWOT Analysis
10.1.6. Key Developments
10.2. 3D SIGNATURES,INC.
10.2.1. Key Facts
10.2.2. Business Description
10.2.3. Products and Services
10.2.4. Financial Overview
10.2.5. SWOT Analysis
10.2.6. Key Developments
10.3. GENOMIC HEALTH
10.3.1. Key Facts
10.3.2. Business Description
10.3.3. Products and Services
10.3.4. Financial Overview
10.3.5. SWOT Analysis
10.3.6. Key Developments
10.4. ABBOTT
10.4.1. Key Facts
10.4.2. Business Description
10.4.3. Products and Services
10.4.4. Financial Overview
10.4.5. SWOT Analysis
10.4.6. Key Developments
10.5. OPKO HEALTH, INC
10.5.1. Key Facts
10.5.2. Business Description
10.5.3. Products and Services
10.5.4. Financial Overview
10.5.5. SWOT Analysis
10.5.6. Key Developments
10.6. SIEMENS HEALTHCARE GMBH
10.6.1. Key Facts
10.6.2. Business Description
10.6.3. Products and Services
10.6.4. Financial Overview
10.6.5. SWOT Analysis
10.6.6. Key Developments
10.7. DIASORIN S.P.A
10.7.1. Key Facts
10.7.2. Business Description
10.7.3. Products and Services
10.7.4. Financial Overview
10.7.5. SWOT Analysis
10.7.6. Key Developments
10.8. BIOMERIEUX SA
10.8.1. Key Facts
10.8.2. Business Description
10.8.3. Products and Services
10.8.4. Financial Overview
10.8.5. SWOT Analysis
10.8.6. Key Developments
10.9. F. HOFFMAN LA ROCHE LTD.
10.9.1. Key Facts
10.9.2. Business Description
10.9.3. Products and Services
10.9.4. Financial Overview
10.9.5. SWOT Analysis
10.9.6. Key Developments
10.10. BECKMAN COULTER, INC
10.10.1. Key Facts
10.10.2. Business Description
10.10.3. Products and Services
10.10.4. Financial Overview
10.10.5. SWOT Analysis
10.10.6. Key Developments
10.11. MYRIAD GENETIC INC
10.11.1. Key Facts
10.11.2. Business Description
10.11.3. Products and Services
10.11.4. Financial Overview
10.11.5. SWOT Analysis
10.11.6. Key Developments
11. APPENDIX
11.1. ABOUT THE INSIGHT PARTNERS
11.2. GLOSSARY OF TERMS

The List of Companies

1. MDxHealth
2. 3D Signatures
3. Genomic Health
4. Abbott
5. OPKO Health, INC.
6. Siemens Healthcare GmbH
7. DiaSorin S.p.A
8. BioMerieux SA
9. F. Hoffman La Roche Ltd.
10. Beckman Coulter, INC.
11. Myriad Genetic Inc

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Medical Device : READ MORE..